首页> 外国专利> SEQUENTIAL ADMINISTRATION OF 20,20,21,21-PENTAFLUORO-17-HYDROXY-11ß-4-(HYDROXYACETYL) PHENYL -19-NOR-17a-PREGNA-4,9-DIENE-3-ONE AND ONE OR MORE PROGESTATIONAL HORMONES FOR TREATING GYNAECOLOGICAL DISEASES

SEQUENTIAL ADMINISTRATION OF 20,20,21,21-PENTAFLUORO-17-HYDROXY-11ß-4-(HYDROXYACETYL) PHENYL -19-NOR-17a-PREGNA-4,9-DIENE-3-ONE AND ONE OR MORE PROGESTATIONAL HORMONES FOR TREATING GYNAECOLOGICAL DISEASES

机译:顺序管理20,20,21,21-五氟-17-羟基-11ß-[4-(羟基乙酰基)苯基] -19-NOR-17a-PREGNA-4,9-二烯-3-一和一个或多个预测治疗妇科疾病的激素

摘要

The invention relates to a treatment regime and to combination preparations of 20,20,21,21,21 -pentafluoro-17-hydroxy-11 ß-[4- (hydroxyacetyl)phenyl]-19-nor-17a-pregna-4,9-diene-3-one of formula (I). Said invention relates to, in particular, a sequential regime for treating gynaecological diseases in which, in a first phase, the above-mentioned progesterone antagonist is administered and, in a second phase, a progestational hormone is administered.
机译:本发明涉及20,20,21,21,21-五氟-17-羟基-11ß-[4-(羟基乙酰基)苯基] -19-nor-17a-pregna-4的治疗方案和组合制剂,式(I)的9-二烯-3-之一。所述发明尤其涉及治疗妇科疾病的顺序方案,其中在第一阶段中,施用上述孕酮拮抗剂,在第二阶段中,施用孕激素。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号